L-phenylalanine degradation I (aerobic)
Pathways in the L-phenylalanine degradation I (aerobic) SuperPath
| # | Name | Source | Genes |
|---|---|---|---|
| 1 | L-phenylalanine degradation I (aerobic) | PubChem | |
| 2 | phenylalanine degradation/tyrosine biosynthesis | PubChem |
Ordered by rank within the SuperPath, via the multiplicity of each gene in the constituent pathways
Disorders associated with L-phenylalanine degradation I (aerobic) SuperPath
according to GeneCards Suite gene sharing
| # | Disorder | Type | Genes | Score |
|---|---|---|---|---|
| 1 | Hyperphenylalaninemia, bh4-deficient, a | Enrichment | PAH, QDPR | 6.01 |
| 2 | Tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria | Enrichment | PAH | 3.53 |
| 3 | Hyperphenylalaninemia, bh4-deficient, c | Enrichment | QDPR | 3.23 |
| 4 | Hyperphenylalaninemia, bh4-deficient, d | Enrichment | PCBD1 | 3.23 |
| 5 | Neurodevelopmental disorder with spasticity, hypomyelinating leukodystrophy, and brain abnormalities | Enrichment | PAH | 3.23 |
| 6 | Pituitary hormone deficiency, combined, 2 | Enrichment | PAH | 3.05 |
| 7 | Hyperphenylalaninemia due to tetrahydrobiopterin deficiency | Enrichment | QDPR | 3.05 |
| 8 | Phenylketonuria | Enrichment | PAH | 2.93 |
| 9 | Propionic acidemia | Enrichment | PAH | 2.93 |
| 10 | Pulmonary hypertension, primary, 1 | Enrichment | PAH | 2.42 |
| 11 | Rasopathy | Enrichment | PAH | 2.12 |
| 12 | Breast cancer | Enrichment | PAH | 1.66 |